H. Lundbeck AS (LTS:0ND5) Total Tax Payable : kr685 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is H. Lundbeck AS Total Tax Payable?

H. Lundbeck AS's Total Tax Payable for the quarter that ended in Mar. 2024 was kr685 Mil.

H. Lundbeck AS's quarterly Total Tax Payable declined from Sep. 2023 (kr692 Mil) to Dec. 2023 (kr571 Mil) but then increased from Dec. 2023 (kr571 Mil) to Mar. 2024 (kr685 Mil).

H. Lundbeck AS's annual Total Tax Payable increased from Dec. 2021 (kr519 Mil) to Dec. 2022 (kr535 Mil) and increased from Dec. 2022 (kr535 Mil) to Dec. 2023 (kr571 Mil).

H. Lundbeck AS Total Tax Payable Historical Data

The historical data trend for H. Lundbeck AS's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

H. Lundbeck AS Total Tax Payable Chart

H. Lundbeck AS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Tax Payable

Get a 7-Day Free Trial

551.00

675.00

519.00

535.00

571.00

H. Lundbeck AS Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Tax Payable	Get a 7-Day Free Trial															660.00	630.00	692.00	571.00	685.00

H. Lundbeck AS Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

H. Lundbeck AS Total Tax Payable Related Terms

Thank you for viewing the detailed overview of H. Lundbeck AS's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

H. Lundbeck AS (LTS:0ND5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » H. Lundbeck AS (LTS:0ND5) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

HLBBF:USA HLUBF:USA 0ABR:UK HLUN A:Denmark HLUN B:Denmark LDBA:Germany

Address

Ottiliavej 9, Valby, DNK, 2500

Website

https://www.lundbeck.com

Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system, or CNS, drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.

H. Lundbeck AS (LTS:0ND5) Headlines

No Headlines